@YellowB55859929 It was reported that artificial intelligence excels at analyzing and uncovering patterns in vast volumes of clinical data โ a fundamental building block in improving patient care.
$SILO has finalized an agreement to sublicense the technology covered by its recently announced provisional #patent applications filed with the @uspto. The patent pertains to Silo Pharmaโs #novel & #proprietary central nervous system (CNS) homing peptides
https://t.co/i7Dt2tGioa
According to long time investor Marc Davis Xphyto Therapeutics could be targeting Lufthansa as well as major European airports and pharmacies with their newly approved Covid-ID Lab test kit: https://t.co/YkI9lfDc89 $XPHY $XPHYF
@NightBe38808851 It was said that a joint effort between various healthcare community representatives seems a much-needed step towards solving common challenges and accelerating the adoption of AI-powered solutions.
@heyman14140094 Accordingly,these other companies appear to be committed to providing superior technological solutions based on precise signal information.
@JacksLyca Accordingly, these other companies launched a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop a next-generation AI
@heyyou99526671 wow! These other companies' technology could potentially reduce processing times from several hours to less than half an hour using the same equipment.
@CherryR47117071@MMilendez With these other companies' technology this means that cash-strapped health authorities throughout Europe and further afield will not be required to purchase any new equipment to run these tests.
@OdetteMage2 @Cutebab01379278 These other companies technology's main competitive advantage appears that it could provide a definitive test result in just 25 minutes with less training, and laboratory requirements than their competitors.